Previous 10 | Next 10 |
Gainers: Rhythm Pharmaceuticals ( RYTM ) +20% . Allakos ( ALLK ) +14% . Senti Biosciences ( SNTI ) +13% . Arcturus Therapeutics ( ARCT ) +7% . Verve Therapeutics ( VERV ) +5% . Losers: Vascular Biogenics ( VBLT ) -78%...
Large and growing TAM with industry tailwinds like digitalization supporting growth in demand for OptimizeRx's solutions. Highly scalable operating model with more than sufficient network capacity to facilitate growth in the near term. OptimizeRx has a strong network of large cust...
ROCHESTER, Mich., June 23, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced a major extension of its omni-channel platform re...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Small-cap stocks have a market capitalization of between $300 million to $2 billion. These stocks are often misunderstood to be risky and speculative. However, small-cap stocks are the best way for investors to get into the...
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation and Persistence Platform, TelaRep is now being used by over 200,000 in-netw...
ROCHESTER, Mich., May 24, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the 42 ...
ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that Mike Rousselle, vice president of data product...
OptimizeRx (NASDAQ:OPRX) has announced that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $20M of its outstanding common stock. Will Febbo, OptimizeRx CEO commented, "The share buyback program highlights the convictio...
ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously a...
ROCHESTER, Mich., May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the RBC H...
News, Short Squeeze, Breakout and More Instantly...
OptimizeRx Corporation Company Name:
OPRX Stock Symbol:
NASDAQ Market:
OptimizeRx Corporation Website:
• 84% of Patients Arrive at Doctor Visits Underinformed • Underscores Growing Importance of HCP and DTC Alignment in Pharma Commercialization and Marketing Strategies • OPRX Closes First Combined HCP and DTC DAAP Marketing Program for Top 5 Pharma Client WAL...
2024-06-13 18:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...